BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 25512528)

  • 1. Allosteric activation of ADAMTS13 by von Willebrand factor.
    Muia J; Zhu J; Gupta G; Haberichter SL; Friedman KD; Feys HB; Deforche L; Vanhoorelbeke K; Westfield LA; Roth R; Tolia NH; Heuser JE; Sadler JE
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18584-9. PubMed ID: 25512528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the "minimal" structure of a functional ADAMTS13 by mutagenesis and small-angle X-ray scattering.
    Zhu J; Muia J; Gupta G; Westfield LA; Vanhoorelbeke K; Tolia NH; Sadler JE
    Blood; 2019 Apr; 133(17):1909-1918. PubMed ID: 30692120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phylogenetic and functional analysis of ADAMTS13 identifies highly conserved domains essential for allosteric regulation.
    Muia J; Zhu J; Greco SC; Vanhoorelbeke K; Gupta G; Westfield LA; Sadler JE
    Blood; 2019 Apr; 133(17):1899-1908. PubMed ID: 30700419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational activation of ADAMTS13.
    South K; Luken BM; Crawley JT; Phillips R; Thomas M; Collins RF; Deforche L; Vanhoorelbeke K; Lane DA
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18578-83. PubMed ID: 25512499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linker regions and flexibility around the metalloprotease domain account for conformational activation of ADAMTS-13.
    Deforche L; Roose E; Vandenbulcke A; Vandeputte N; Feys HB; Springer TA; Mi LZ; Muia J; Sadler JE; Soejima K; Rottensteiner H; Deckmyn H; De Meyer SF; Vanhoorelbeke K
    J Thromb Haemost; 2015 Nov; 13(11):2063-75. PubMed ID: 26391536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model for the conformational activation of the structurally quiescent metalloprotease ADAMTS13 by von Willebrand factor.
    South K; Freitas MO; Lane DA
    J Biol Chem; 2017 Apr; 292(14):5760-5769. PubMed ID: 28209710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of von Willebrand factor scissile bond cleavage by a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13).
    Xiang Y; de Groot R; Crawley JT; Lane DA
    Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11602-7. PubMed ID: 21705658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboxyl terminus of ADAMTS13 directly inhibits platelet aggregation and ultra large von Willebrand factor string formation under flow in a free-thiol-dependent manner.
    Bao J; Xiao J; Mao Y; Zheng XL
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):397-407. PubMed ID: 24357063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADAMTS13 and von Willebrand factor interactions.
    Zander CB; Cao W; Zheng XL
    Curr Opin Hematol; 2015 Sep; 22(5):452-9. PubMed ID: 26186678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cooperative activity between the carboxyl-terminal TSP1 repeats and the CUB domains of ADAMTS13 is crucial for recognition of von Willebrand factor under flow.
    Zhang P; Pan W; Rux AH; Sachais BS; Zheng XL
    Blood; 2007 Sep; 110(6):1887-94. PubMed ID: 17540842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structures of the noncatalytic domains of ADAMTS13 reveal multiple discontinuous exosites for von Willebrand factor.
    Akiyama M; Takeda S; Kokame K; Takagi J; Miyata T
    Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19274-9. PubMed ID: 19880749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleavage of von Willebrand factor requires the spacer domain of the metalloprotease ADAMTS13.
    Zheng X; Nishio K; Majerus EM; Sadler JE
    J Biol Chem; 2003 Aug; 278(32):30136-41. PubMed ID: 12791682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential domains of a disintegrin and metalloprotease with thrombospondin type 1 repeats-13 metalloprotease required for modulation of arterial thrombosis.
    Xiao J; Jin SY; Xue J; Sorvillo N; Voorberg J; Zheng XL
    Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2261-9. PubMed ID: 21799176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular biology of ADAMTS13 and diagnostic utility of ADAMTS13 proteolytic activity and inhibitor assays.
    Shelat SG; Ai J; Zheng XL
    Semin Thromb Hemost; 2005 Dec; 31(6):659-72. PubMed ID: 16388417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure and substrate-induced activation of ADAMTS13.
    Petri A; Kim HJ; Xu Y; de Groot R; Li C; Vandenbulcke A; Vanhoorelbeke K; Emsley J; Crawley JTB
    Nat Commun; 2019 Aug; 10(1):3781. PubMed ID: 31439947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of ADAMTS13 to von Willebrand factor.
    Majerus EM; Anderson PJ; Sadler JE
    J Biol Chem; 2005 Jun; 280(23):21773-8. PubMed ID: 15824096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF.
    Zanardelli S; Chion AC; Groot E; Lenting PJ; McKinnon TA; Laffan MA; Tseng M; Lane DA
    Blood; 2009 Sep; 114(13):2819-28. PubMed ID: 19587373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Light chain of factor VIII is sufficient for accelerating cleavage of von Willebrand factor by ADAMTS13 metalloprotease.
    Cao W; Sabatino DE; Altynova E; Lange AM; Casina VC; Camire RM; Zheng XL
    J Biol Chem; 2012 Sep; 287(39):32459-66. PubMed ID: 22854959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant CUB-1 domain polypeptide inhibits the cleavage of ULVWF strings by ADAMTS13 under flow conditions.
    Tao Z; Peng Y; Nolasco L; Cal S; Lopez-Otin C; Li R; Moake JL; López JA; Dong JF
    Blood; 2005 Dec; 106(13):4139-45. PubMed ID: 16141351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor.
    Crawley JT; de Groot R; Xiang Y; Luken BM; Lane DA
    Blood; 2011 Sep; 118(12):3212-21. PubMed ID: 21715306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.